Jacqueline L Lockwood, NP
Nurse Practitioner · Austin
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 18 years
- Graduated 2008
Offices
1 location · Aa Obgyn PLLC · 38 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Jacqueline L Lockwood’s office at (512) 451-8211 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$929
Medicare paid this office $929 for 13 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
13 Original Medicare patients in 2024. Average age 67 · Women 100% · Also on Medicaid 0% · Health risk score 0.48. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
The office billed $3,260, Medicare allowed $1,021 and paid $929; for 21 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$6,753
Pharmacies billed $6,753 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 141) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
127 generic and 14 brand-name prescriptions · $6,753 in drug cost · 19 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ondansetron Odt | 21 | $188 | $9 |
| Levothyroxine | 16 | $121 | $8 |
Year by year
| 2024 | 141 | 84 | 0% (0) | 10% | $6,753 |
| 2023 | 108 | 38 | 0% (0) | 44% | $48,711 |
| 2022 | 112 | 37 | 0% (0) | None | $30,937 |
| 2021 | 86 | 28 | 0% (0) | None | $6,876 |
| 2020 | 41 | 17 | 0% (0) | None | $4,734 |
| 2018 | 17 | None | 0% (0) | None | $903 |
| 2017 | 17 | None | 0% (0) | None | $2,040 |
| 2016 | 13 | None | 0% (0) | None | $1,220 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Mounjaro | 23 | $27,245 | $1,185 |
| Ozempic | 18 | $17,293 | $961 |
2022: 1 drug
| Mounjaro | 16 | $16,668 | $1,042 |
2021: 1 drug
| Yuvafem | 14 | $1,218 | $87 |
Money from drug and device companies
$369 in 2025
| 2025 | 6 | 18 | None | $369 |
| 2024 | 5 | 34 | None | $513 |
| 2023 | 8 | 20 | None | $374 |
| 2022 | 10 | 16 | None | $263 |
| 2021 | 13 | 50 | None | $836 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mayne Pharma Commercial | None | $90 | 3 payments
|
| Shield Therapeutics | Accrufer | $75 | 3 payments
|
| Biogen | Zurzuvae | $69 | 4 payments
|
| Abbvie | Ubrelvy | $56 | 3 payments
|
| Pfizer | Nurtec Odt | $46 | 3 payments
|
| Millicent US | Femlyv | $34 | 2 payments
|
See all 18 published payments
| Mayne Pharma Commercial | Meals · 2025-12-09 | None | $32 |
| Shield Therapeutics | Meals · 2025-12-08 | Accrufer | $25 |
| Abbvie | Meals · 2025-12-02 | Liletta | $23 |
| Abbvie | Meals · 2025-11-12 | Ubrelvy | $18 |
| Mayne Pharma Commercial | Meals · 2025-11-11 | None | $23 |
| Millicent US | Meals · 2025-10-07 | Femlyv | $19 |
| Shield Therapeutics | Meals · 2025-09-23 | Accrufer | $29 |
| Biogen | Meals · 2025-06-12 | Zurzuvae | $17 |
| Mayne Pharma Commercial | Meals · 2025-06-10 | None | $34 |
| Pfizer | Meals · 2025-06-04 | Nurtec Odt | $16 |
| Abbvie | Meals · 2025-05-09 | Ubrelvy | $15 |
| Shield Therapeutics | Meals · 2025-04-29 | Accrufer | $21 |
| Millicent US | Meals · 2025-04-22 | Intrarosa | $15 |
| Pfizer | Meals · 2025-03-05 | Nurtec Odt | $16 |
| Biogen | Meals · 2025-02-18 | Zurzuvae | $18 |
| Biogen | Meals · 2025-02-18 | Zurzuvae | $19 |
| Pfizer | Meals · 2025-02-04 | Nurtec Odt | $14 |
| Biogen | Meals · 2025-01-07 | Zurzuvae | $15 |
See earlier years (2024, 2023, 2022, 2021)
2024: $513
| Abbvie | Ubrelvy | $188 | 13 payments
|
| Pfizer | Myfembree | $164 | 13 payments
|
| Novo Nordisk | Wegovy | $95 | 4 payments
|
| Millicent US | Intrarosa | $35 | 2 payments
|
| Exeltis USA | Slynd | $31 | 2 payments
|
2023: $374
| Abbvie | Ubrelvy | $194 | 11 payments
|
| Novo Nordisk | Saxenda | $39 | 2 payments
|
| Astellas Pharma US | Myrbetriq | $29 | 1 payment
|
| Pfizer | Myfembree | $27 | 2 payments
|
| Abbott Laboratories | Freestyle Libre 2 | $27 | 1 payment
|
| Hologic Sales and Service | Novasure | $23 | 1 payment
|
| Millicent US | Intrarosa | $20 | 1 payment
|
| Exeltis USA | Slynd | $16 | 1 payment
|
2022: $263
| Novo Nordisk | Rybelsus | $58 | 3 payments
|
| Agile Therapeutics | Twirla | $50 | 3 payments
|
| Abbvie | Lo Loestrin Fe | $35 | 2 payments
|
| Exeltis USA | Slynd | $29 | 2 payments
|
| Evofem Biosciences | Phexxi | $19 | 1 payment
|
| Pfizer | Premarin | $18 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $14 | 1 payment
|
| Currax Pharmaceuticals | Contrave | $13 | 1 payment
|
| Avion Pharmaceuticals | Balcoltra | $13 | 1 payment
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $13 | 1 payment
|
2021: $836
| AbbVie | Lo Loestrin Fe | $326 | 20 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $116 | 7 payments
|
| Evofem Biosciences | Phexxi | $68 | 3 payments
|
| Novo Nordisk | Saxenda | $57 | 4 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $47 | 3 payments
|
| TherapeuticsMD | Annovera | $47 | 3 payments
|
| Hologic | Thinprep 2000 Processor | $44 | 2 payments
|
| Agile Therapeutics | Twirla | $43 | 2 payments
|
| Mylan Pharmaceuticals | Xulane | $30 | 2 payments
|
| Pfizer | Premarin | $18 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $15 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $13 | 1 payment
|
| Avion Pharmaceuticals | Balcoltra | $13 | 1 payment
|
Professional record
- NPI
- 1497045561
- Licence
- TX 117327
- Group
- Aa Obgyn PLLC
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 12200 Renfert Way Ste 100, Austin, TX, 78758
- NPI first listed
- 2011-04-11
- NPI last updated
- 2023-12-13
- NPI record certified
- 2023-06-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 530 Lytton Ave Fl 2, Palo Alto, CA, 94301